CVE-2026-108920: sourcecodester drug recommendation system Cross-site Scripting

Vulnerability summary

CVE-2026-108920 is a medium (CVSS 5.3) Cross-site Scripting vulnerability in sourcecodester drug recommendation system. EPSS estimates a 0.26% chance of exploitation in the next 30 days, higher than 17% of scored vulnerabilities.

Timeline

1. 12-10-2026
   PublishedVulnerability first disclosed.
2. 15-10-2026
   Last modifiedVulnerability information updated.

Description

A security vulnerability has been detected in SourceCodester Drug Recommendation System 1.0. This affects an unknown function of the file Admin/user_record.php of the component Admin Record Tables. Such manipulation of the argument name/email leads to cross site scripting. The attack can be launched remotely. The exploit has been disclosed publicly and may be used.

• CWE-79Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users.
• CWE-94Improper Control of Generation of Code ('Code Injection')The product constructs all or part of a code segment using externally-influenced input from an upstream component, but it does not neutralize or incorrectly neutralizes special elements that could modify the syntax or behavior of the intended code segment.